Jubilant Pharmova approves grant of 2,07,003 stock options/RSUs/PSUs

Jubilant Pharmova Ltd's Nomination, Remuneration and Compensation Committee, via a circular resolution on July 16, 2026, approved the grant of 2,07,003 Stock Options/Restricted Stock Units (RSUs)/Performance Stock Units (PSUs) to eligible employees. This grant falls under the Jubilant Pharmova Employees Stock Option Plan 2018 and complies with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The grant includes 1,81,570 RSUs/PSUs with an exercise price of ₹1 each and 25,433 Stock Options with an exercise price of ₹974.45 each. Vesting conditions vary, with some RSUs vesting in 3 years based on performance, stock options vesting over 5 years (20%, 30%, 50%), and PSUs vesting on April 1, 2029. The exercise period for RSUs/PSUs is 1 year from vesting, while for stock options it is 8 years from the grant date.